Guided Therapeutics Inc (OTCBB:GTHP) was a massive decliner during the trading session on Tuesday. The stock collapsed by close to 31% on the back of high volumes, which were 8 times the daily average volumes. The stock was unable to move above the resistance zone at $0.04 and witnessed huge selling pressure, which points towards bears being in total control at the moment. The stock currently trades below all daily moving averages. The indicator for relative strength has given a clear indication of the strong bearish momentum. Traders see the stock heading to levels of $0.02 in the near term.


Guided Therapeutics Inc (OTCBB:GTHP) has announced financial results for the recently concluded 3Q2015. As per the reports, the quarterly revenues of the company were recorded as $94,000.

Guided Therapeutics is known for developing a painless and rapid testing platform on the basis of patented biophotonic technology.

Insights of Financial Results  

The volatile market condition and below average customer response led to a reduction in revenues over the past 12 months time. Guided Therapeutics had reported $262,000 in revenues during the 3Q2014, which came down to $94,000 in the recently concluded third quarter. When contacted, Guided Therapeutics said that the primary reason for this sharp decline was nothing but lower-than-expectations shipment of 160 single-use disposables and six units of LuViva as compared to last year’s 5,380 disposables and 13 units.

In addition to this, the operating expenses of the company came down to $1,710,000 in 3Q2015 compared to $2,439,000 in 3Q2014. The entire management team of the company was happy to acknowledge that the continuous hard work and devotion led to this situation. E

ven though it managed to bring down the operating cost, the profitable state’s out of reach. Reports claim that the net loss available to shareholders for the quarter was $2.7 million compared to $3 million during the same period in 2014. Guided Therapeutics said that lower than expectations revenues led the company to this position.

Recently, the Turkish distributor of Guided Therapeutics signed a deal with Turkish Ministry of Health to sell single-use disposables and LuViva devices worth $10 million. It has already surged the order by $4 million and can further enhance it if need be.

According to Gene Cartwright, CEO, Guided Technologies, the 3rd quarter was one of those three month periods for the company in which it executed various initiatives to scale its business. Guided Technologies has done a lot of hard work to enhance its reach in Turkey lately, and will continue these efforts in the future as well.

Previous articleTimothy Trant Is The New Chief Customer Officer At Barfresh Food Group Inc (OTCMKTS:BRFH)
Next articleUmax Group Corp (OTCMKTS:UMAX) Appoints Robert Haltom As The New Public Relations Officer
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.